Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-14 Purchase | 2024-11-18 7:20 pm | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 20,000 | $3.7 | $74,000 | 31,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-05 Option Award | 2024-06-07 5:17 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 43,750 | $0 | 48,750 (Direct) | View |
2024-06-05 Option Award | 2024-06-06 8:30 pm | 2025-06-05 2034-06-05 | Surrozen Inc. | SRZN | Rothenberg Mace Director | 1,333 | $0 | 1,333 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:40 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 35,000 | $0 | 35,000 (Direct) | View |
2023-05-18 Option Award | 2023-05-19 4:17 pm | 2023-06-18 2033-05-18 | Surrozen Inc. | SRZN | Rothenberg Mace Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-08 Option Award | 2022-06-28 4:27 pm | N/A 2032-06-08 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:50 pm | 2023-06-07 2032-06-07 | Surrozen Inc. | SRZN | Rothenberg Mace Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-08-16 7:49 pm | N/A N/A | Surrozen Inc. | SRZN | Rothenberg Mace Director | 0 | $0 | 35,129 (Direct) | View |
Ownership | 2021-08-12 8:38 pm | N/A 2031-03-18 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 0 | $0 | 84,929 (Direct) | View |